GHK-Cu
Copper tripeptide-1 · GHK copper · Gly-His-Lys-Cu
1What it is
GHK is a three-amino-acid fragment found naturally in plasma, saliva and urine. Its blood level falls with age — roughly 200 ng/ml at 20 to about 80 ng/ml at 60.
It has been a cosmetic ingredient since the 1990s and is the one peptide on this site that many people already use without knowing it.
2How it's thought to work
3What the research shows
Skin ageing (topical)
Wound healing
Lung repair / COPD
Systemic injection
4Reported side effects and interactions
Literature-reported
Topical: well tolerated; rare contact irritation.Community-reported
Injectable: notable pain and burning at the injection site, redness, bruising; occasional nausea or headache.Interactions. None established. Strong vitamin C or AHAs may destabilise the copper complex if layered immediately.
Markers researchers commonly monitor
| Marker | Why it's watched |
|---|---|
| Serum copper, ceruloplasmin | Repeated systemic copper administration |
Free for everyone. Safety information is never behind a paywall.
5Reconstitution and handling
Supplied as blue powder, commonly 50 mg vials. The solution should be clear blue; a fading or green-brown solution suggests degradation.
Open in calculator, pre-loaded →6Commonly studied alongside
Informational cross-links. Not stack recommendations.
7Regulatory status by region
| Region | Status (checked —) |
|---|---|
| United States | Permitted cosmetic ingredient. Injectable not FDA-approved |
| European Union | Permitted cosmetic ingredient; injectable not authorised |
| United Kingdom | Same as EU |
| Australia | Cosmetic use permitted; injectable not approved |
| South Africa | Cosmetic use permitted; injectable not registered |
| Canada | Cosmetic use permitted |
| Sport | Not specifically listed by WADA |
8Open questions
- Does topical GHK-Cu penetrate deeply enough to explain reported dermal effects?
- Any benefit from systemic injection in humans — untested.
9References
- 1Pickart L et al. (2015). GHK peptide as a natural modulator of multiple cellular pathways. Biomed Res Int. PubMed · DOI
- 2Pickart L, Margolina A (2018). Regenerative and protective actions of GHK-Cu. Int J Mol Sci. PubMed
- 3Campbell JD et al. (2012). A gene expression signature of emphysema reversal by GHK. Genome Med. PubMed
- 4Pickart L, Thaler MM (1973). Tripeptide in human serum. Nat New Biol. PubMed
- 5Abdulghani AA et al. (1998). Topical creams compared with tretinoin. Dis Manag Clin Outcomes. PubMed
- 6Mulder GD et al. (1994). Enhanced healing of ulcers in diabetes by GHK-Cu. Wound Repair Regen. PubMed
References are being resolved to PubMed/DOI identifiers; links search PubMed for the citation until then.
10Community
Threads and protocols are visible to members. Joining is free.
Self-reported side effects Phase 2
11Page history
Licensed CC BY-NC-SA 4.0. Found an error? Report it · Editorial standards — corrections are logged here.